Agonist substitution for high-dose benzodiazepine-dependent patients: Let us not forget the importance of flumazenil

Addiction

Volumn 106, Issue 4, 2011, Pages 853-

  Lugoboni, Fabio ^a   Faccini, Marco ^a   Quaglio, Gianluca ^a   Casari, Rebecca ^a   Albiero, Anna ^a   Pajusco, Benedetta ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Benzodiazepine; Dependence; Detoxification; Flumazenil; Infusion; Substitution

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; FLUMAZENIL;

ADDICTION; HUMAN; NOTE;

BENZODIAZEPINES; FLUMAZENIL; GABA MODULATORS; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 79952305154     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03327.x     Document Type: Letter

References (5)

1. Liebrenz M., Boesch L., Stohler R., Caflisch C. Agonist substitution-a treatment for high-dose benzodiazepine-dependent patients? Addiction 2010; 105: 1870-4.
2. Gerra G., Giucasto G., Zaimovic A., Fertonani G., Chittolini B., Avanzini P. etal. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal. Int Clin Psychopharmacol 1996; 11: 81-8.
3. Gerra G., Zaimovich A., Giusti F., Moi G., Brewer C. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Addict Biol 2002; 7: 385-95.
4. Quaglio G., Lugoboni F., Fornasiero A., Lechi A., Gerra G., Mezzelani P. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion. Int Clin Psychopharmacol 2005; 20: 285-7.
5. Hood S., O'Neil G., Hulse G. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles. J Psychopharmacol 2009; 23: 401-9.